Acciones HedgePath Pharmaceuticals Inc
Acciones
US42278K1025
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+41,04 % | 50,93 mil M | |
-0,40 % | 42,12 mil M | |
+49,62 % | 42,05 mil M | |
-7,20 % | 29,18 mil M | |
+12,83 % | 26,02 mil M | |
-21,45 % | 18,9 mil M | |
+7,04 % | 13,21 mil M | |
+24,52 % | 12,17 mil M | |
+30,49 % | 12,16 mil M |